Profluent's $2.25B Lilly Deal and Why Treating Proteins as a Language Modeling Problem Is a Bigger Story Than the Headline Suggests: Scaling Laws, Synthetic Biology, and the Compute Substrate Thesis

Thoughts on Healthcare Markets & Technology Podcast

0:00

-6:55

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

Profluent's $2.25B Lilly Deal and Why Treating Proteins as a Language Modeling Problem Is a Bigger Story Than the Headline Suggests: Scaling Laws, Synthetic Biology, and the Compute Substrate Thesis

Eli Lilly just paid $2.25 billion for the thesis that protein sequences are text and foundation models can design biology from scratch.

May 04, 2026

∙ Paid

Quick Links: Knowledge Base, Podcast, and Social

Knowledge Base — search and filter every article and podcast episode by topic, section, and keyword: kb.onhealthcare.tech

Listen to the Podcast — every article is also available as an audio episode. Free subscribers get the public episodes; paid subscribers get the full archive including subscriber-only epi…

Continue reading this post for free, courtesy of Thoughts on Healthcare.

Or purchase a paid subscription.